Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Does atovaquone provide effective prophylaxis for Pneumocystis pneumonia in children with leukemia?

Nature Clinical Practice Oncology volume 4, pages 566–567 (2007)Cite this article

boxed-textMadden RM et al. (2007) Prophylaxis of Pneumocystis carinii pneumonia with atovaquone in children with leukemia. Cancer 109: 1654–1658

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Hughes WT et al. (1977) Successful chemoprophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med 297: 1419–1426

    Article  CAS  Google Scholar 

  2. Tuan IZ et al. (1992) Pneumocystis carinii pneumonitis following bone marrow transplantation. Bone Marrow Transplant 10: 267–272

    CAS  PubMed  Google Scholar 

  3. Chan C et al. (1999) Atovaquone suspension compared with aerosolized pentamidine for prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected subjects intolerant of trimethoprim or sulfonamides. J Infect Dis 180: 369–376

    Article  CAS  Google Scholar 

  4. El-Sadr WM et al. (1998) Atovaquone compared with dapsone for the prevention of Pneumocystis carinii pneumonia in patients with HIV infection who cannot tolerate trimethoprim, sulfonamides, or both. Community Program for Clinical Research on AIDS and the AIDS Clinical Trials Group. N Engl J Med 339: 1889–1895

    Article  CAS  Google Scholar 

  5. Hughes W et al. (1993) Comparison of atovaquone (566C80) with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS. N Engl J Med 328: 1521–1527

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by the Intramural Research Program of the NIH Clinical Center. The synopsis was written by Petra Roberts, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. CG Morse is a Staff Clinician and JA Kovacs is a Senior Investigator at the NIH Clinical Center, Bethesda, MD, USA.,

    Caryn G Morse & Joseph A Kovacs

Authors
  1. Caryn G Morse
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joseph A Kovacs
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Joseph A Kovacs.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Morse, C., Kovacs, J. Does atovaquone provide effective prophylaxis for Pneumocystis pneumonia in children with leukemia?. Nat Rev Clin Oncol 4, 566–567 (2007). https://doi.org/10.1038/ncponc0927

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncponc0927

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing